- In November 2024, Gemini BioProducts LLC has acquired selected fetal bovine serum (FBS) product rights and inventory from Bio-Techne. This acquisition enables Gemini BioProducts to expand its portfolio and strengthen its position in the life sciences market. By gaining access to Bio-Techne's FBS products, Gemini will enhance its ability to offer high-quality cell culture media, supporting a broad range of applications in research, biotechnology, and pharmaceutical industries. This move is expected to provide greater product availability, improve supply chain efficiency, and meet the increasing demand for reliable research materials globally
